NEJM March 12 2026 Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia

This Week In Medicine · Mar 12, 2026 · 20m

This study evaluates whether time-limited drug combinations are as effective as lifelong daily medication for patients newly diagnosed with chronic lymphocytic leukemia. By comparing three specific drug regimens over a three-year period, researchers found that the shorter, fixed-duration treatments performed just as well at keeping the cancer from progressing as the standard continuous therapy. Notably, the fixed-duration groups showed significantly higher rates of undetectable residual disease, suggesting that intensive, brief therapy can achieve deep remission. Ultimately, the trial proves…